Authors
Latest:
Patient and Clinical Perspectives on Advancing MS Care Through Treatment, Advocacy, and ResearchA patient and neurologist discussed personal and professional perspectives on treatment initiation, ongoing research, and patient advocacy in multiple sclerosis. [WATCH TIME: 5 minutes]
Latest:
Emerging Agents in Alzheimer’s DiseasePanelists discuss how emerging therapeutic targets, including amyloid-beta plaques, tau protein aggregation, inflammation modulation, and mitochondrial dysfunction, offer promising approaches for disease-modifying treatments in early Alzheimer's disease.
Latest:
Key Takeaways and Future Opportunities for WVE-004: Michael Panzara, MD, MPHThe chief medical officer of Wave Life Sciences outlined the FOCUS-C9 study, which has incorporated feedback from patients with both ALS and FTD, as well as investigators in the research field.
Latest:
Stephen Cunnane, PhD: Evaluating Ketogenics in Brain Energy RescueThe professor from the Universite de Sherbrooke discusses the use of ketogenic diets and supplements to increase cognition.
Latest:
Future Research Directions for DCTclock and the Potential to Predict Alzheimer Biomarkers: Ali Jannati, MD, PhDThe manager of Clinical Development-Research at Linus Health discussed potential avenues of research for the DCTclock and expanding its capabilities as a potential detector of cognitive decline. [WATCH TIME: 3 minutes]
Latest:
Building a Large-Scale Database of Genetic Associations to Alzheimer Disease: Margaret Pericak-Vance, PhDThe director of the John P. Hussman Institute for Human Genomics at the University of Miami detailed a new international initiative that expands on the genetic backgrounds of people of Hispanic and African ancestry. [WATCH TIME: 4 minutes]
Latest:
Expanding Research of Sleep and Cognitive Risks Associated: Christian Agudelo, MDThe Evelyn F. McKnight Neurocognitive Scholar at the University of Miami Miller School of Medicine discussed observing how sleep may impact cognitive decline in different populations.
Latest:
Evaluating 3K3A-APC in Patients With ALS: Kent Pryor, PhDThe CEO of ZZ Biotech outlined the design of the phase 2 trial of 3KA-APC, which will enroll 16 patients with amyotrophic lateral sclerosis. [WATCH TIME: 4 minutes]
Latest:
Incorporation of Registered Dietitians in MS Care: Tyler Titcomb, PhD, RDN, IFMCPThe postdoctoral scholar at the University of Iowa commented on why the multiple sclerosis field should lean on registered dietitians to help alleviate symptoms of patients with multiple sclerosis. [WATCH TIME: 2 minutes]
Latest:
Let’s Get Moving: A Multidisciplinary Approach to Gait Rehabilitation in Multiple SclerosisCurrent research pushes to advance therapeutic possibilities and understand underlying neural mechanisms for gait impairments in individuals with the disease.
Latest:
Muscular Dystrophy Association: A Hybrid Conference Featuring the Latest Advances in Neuromuscular Research, Therapy, and Clinical CareThe Muscular Dystrophy Association's annual meeting will take place in-person and virtually in Nashville, Tennessee, on March 13-16, with more than 950 in-person attendees and 130 presenters.
Latest:
Future of Cognition in Multiple SclerosisAhmed Obeidat, MD, PhD; Randall Schapiro, MD, FAAN; and Jeffrey Wilken, PhD, share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.
Latest:
Clinicians Express Growing Optimism in ALS Research and Treatment AdvancementsExperts in ALS care and research shared their optimism about emerging treatments, aiming to deepen scientific understanding, and the potential role of advocacy in accelerating progress. [WATCH TIME: 4 minutes]
Latest:
Adjusting Motor Fluctuation Management in an Era of Neuromodulation: Laxman Bahroo, DOThe professor of neurology and resident program director at MedStar Georgetown University Hospital discussed how Parkinson disease motor fluctuations are managed amid new, novel technologies incorporated in the field. [WATCH TIME: 4 minutes]
Latest:
Therapeutics Aim at Modifying Alzheimer DiseaseDisease-modifying agents will require early detection, including comprehensive evaluation of disease severity and alternative or confounding diagnoses. When the long-awaited moment arrives, when disease-modifying therapies finally are available for ADRDs…will we be ready?
Latest:
Role of Advocacy Organizations in Creating Safe Spaces for Rare DisordersA panel of neurology experts detailed the importance that community leadership and creating a positive environment can do for patients with rare neurologic disorders [WATCH TIME: 5 minutes]
Latest:
Barriers in Conducting Real-World Dementia Studies: XinQi Dong, MD, MPHThe director of the Institute for Health, Health Care Policy, and Aging Research at Rutgers University discussed the reasons behind the lack of real-world dementia studies.
Latest:
AUPN Leadership Minute Episode 20: Putting the Burn on BurnoutEpisode 20 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Cormac O'Donovan, MD, of Wake Forest Baptist. [WATCH TIME: 4 minutes]
Latest:
A Team Approach to Asleep Deep Brain StimulationHenry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.
Latest:
Advantages to Directly Transferring Stroke Treatment to Angiography: Shazam Hussain, MD, FRCP, FAHAThe director of Cleveland Clinic’s Cerebrovascular Center discussed the decisions mobile stroke units face and why opting for direct transfer to angiography is meant for certain scenarios. [WATCH TIME: 3 minutes]
Latest:
Comparable Evidence of Telehealth Benefits vs In-Person Care for Pediatrics: Gogi Kumar, MDThe division chief of child neurology at Dayton Children’s Hospital discussed findings from a study comparing patient satisfaction scores between telehealth and in-person visits in pediatric epilepsy care. [WATCH TIME: 4 minutes]
Latest:
IJMSC Insights: Kathleen Costello, Interim CEO of CMSCIJMSC Insights offers a closer look at the latest research and the people behind it from the community of the International Journal of Multiple Sclerosis Care (IJMSC) and the Consortium of Multiple Sclerosis Centers (CMSC).
Latest:
Clinical Takeaways From INP104 Data in Migraine: Sheena K. Aurora, MDThe vice president of Medical Affairs in Migraine at Impel discussed the clinical takeaways from the STOP 301 trial of intranasal DHE and the advantages that the novel formulation might offer patients with migraine.
Latest:
Future Directions and Takeaways Regarding Anti-CD20 Therapies in MSAhmed Obeidat, MD, PhD, Riley Bove, MD, Stephen Krieger, MD, and Erin Longbrake, MD, PhD, share perspectives on the future of MS care, the importance of vigilance in lab testing, and why patients may need reassurance about the potential for disease control with currently available therapies.
Latest:
Improving Patient Communication in MGExpert neurologists share thoughts on how to improve patient/physician communication and how listening to the patient needs will aid in managing MG.
Latest:
Development of Neuropathology Targeted Treatments in Alzheimer Disease: Madhav R. Thambisetty, MD, PhDThe senior investigator at the National Institute on Aging talked about targeting pathologies in neurodegenerative diseases at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Latest:
Efficacy of Adjunctive Therapies for Acute Ischemic Stroke Based on Phase 3 MOST Trial: Opeolu Adeoye, MD, MS; Andrew Barerrto, MD, MSThe professor of emergency medicine at Washington University in St. Louis and associate professor of neurosurgery at UTHealth Houston talked about results from the phase 3 MOST trial assessing argatroban and eptifibatide in acute ischemic stroke. [WATCH TIME: 3 minutes]
Latest:
Exploring Remyelination and Functional Recovery With Vagus Nerve Stimulation in MS: Cristin Welle, PhDThe professor of neurosurgery and physiology at University of Colorado School of Medicine talked about how vagus nerve stimulation may promote remyelination and functional recovery in multiple sclerosis. [WATCH TIME: 4 minutes]
Latest:
Telehealth and Integrative Medicine for Multiple Sclerosis: Megan Weigel, DNP, APRN-C, APHN-C, MSCNDiscussing a 6-week, virtual program conducted over Zoom, the founder of First Coast Integrative Medicine, spoke on the use of telehealth and future research efforts for integrative medicine in MS. [WATCH TIME: 3 minutes]
